🇺🇸 FDA
Drug

durvalumab

Brand: IMFINZI

approved

Quick answer

durvalumab (IMFINZI), is a pharmaceutical active ingredient, with approved status in the US.

Key facts

INN
durvalumab
Brand
IMFINZI
Route
INJECTION
Formulation
INJECTABLE

Related news

FDA Approves Imfinzi: Breakthrough for Stage III NSCLC Treatment
NewsNon-Small Cell Lung CancerApr 8, 2026

FDA Approves Imfinzi: Breakthrough for Stage III NSCLC Treatment

The FDA's approval of Imfinzi offers new hope for patients with Stage III non-small cell lung cancer (NSCLC), enhancing treatment possibilities.

Dr. Sarah Mitchell

Frequently asked questions

What is durvalumab?

durvalumab (IMFINZI), is a pharmaceutical active ingredient, with approved status in the US.

What is the brand name for durvalumab?

IMFINZI is a marketed brand name for durvalumab. Check FDA Drugs@FDA for the current US label holder.